Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
Tue, 24.11.2020
SFC Energy AG
SFC Energy AG
Publication of Insider Information pursuant to Article 17 of Regulation (EU) No. 596/2014 - ISIN DE0007568578
NOT FOR DISTRIBUTION, PUBLICATION OR TRANSMISSION, EITHER DIRECTLY OR INDIRECTLY, IN FULL OR IN EXCERPTS, IN OR TO THE UNITED STATES OF AMERICA, CANADA, AUSTRALIA, JAPAN OR ANY OTHER JURISDICTION IN WHICH SUCH DISTRIBUTION, [ … ]
Tue, 24.11.2020
SFC Energy AG
SFC Energy AG
Publication of Insider Information pursuant to Article 17 of Regulation (EU) No. 596/2014 - ISIN DE0007568578
NOT FOR DISTRIBUTION, PUBLICATION OR TRANSMISSION, EITHER DIRECTLY OR INDIRECTLY, IN FULL OR IN EXCERPTS, IN OR TO THE UNITED STATES OF AMERICA, CANADA, AUSTRALIA, JAPAN OR ANY OTHER JURISDICTION IN WHICH SUCH DISTRIBUTION, [ … ]
Tue, 24.11.2020
Trintech, Inc.
Trintech Announces the Expansion of Its Executive Team with the Addition of a Chief Human Resources Officer
Felicia Taylor to oversee global HR function as Trintech continues to expand and add talent worldwide
DALLAS, TX / ACCESSWIRE / November 24, 2020 / Trintech, a leading global provider of integrated Record to Report software solutions for th [ … ]
Tue, 24.11.2020
4finance S.A.
4finance announces senior management promotions
24 November 2020. 4finance Group S.A. (the "Group"), one of Europe's largest digital consumer lending groups, announces the appointment of James Etherington as Group CFO and Marek Kujawa as Group CRO, effective 1 December 2020.
James Etherington was previously head of investor relations at 4finance [ … ]
Tue, 24.11.2020
Immunic, Inc.
Immunic, Inc. to Participate in Investor Conferences in December
NEW YORK, November 24, 2020 - Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, today announced management's participation in the follow [ … ]
Tue, 24.11.2020
Traumhaus AG
Unternehmensgruppe Nassauische Heimstätte | Wohnstadt acquires a further building section of Traumhaus AG
- Another forward deal closed
- Start of construction in the 2nd half of 2021
Wiesbaden 24 November 2020 - Traumhaus AG has sold a further construction phase in Wiesbaden to the Nassauische Heimstätte | Wohnstadt (NHW) group of companies. [ … ]
Tue, 24.11.2020
MetrioPharm AG
EQS Group-News: MetrioPharm AG
/ Key word(s): Scientific publication/Study
MetrioPharm AG: COVID-19 Therapeutic Agent: MetrioPharm Prepares to Conduct a Phase II Clinical Trial
24.11.2020 / 12:05
- Drug Candidate exerts strong SARS-CoV-2 specific antiviral properties in the in vitro infection test
- Preclinical data were pub [ … ]
Tue, 24.11.2020
PREOS Global Office Real Estate & Technology AG
Press Release
Majority shareholder of PREOS brings "digital twin" of PREOS share onto the Blockchain
- First tokenisation of shares of a listed company worldwide
- Public offer based on securities prospectus as of 24 November 2020
- Subscription starting from one token possible - signal effect for financial centre Germany
- Thomas Olek, founde [ … ]
Tue, 24.11.2020
publity AG
Press Release
publity AG brings "digital twin" of the PREOS share onto the Blockchain
- First tokenisation of shares of a listed company worldwide
- Public offer based on securities prospectus as of 24 November 2020
- Subscription starting from one token possible - signal effect for financial centre Germany
- Thomas Olek, CEO, of publity AG [ … ]
Tue, 24.11.2020
Fabasoft AG
Fabasoft AG (ISIN AT0000785407, WKN 922985, Prime Standard) announced on
24 November 2020 Group figures for the first half of the fiscal year 2020/2021
(01/04/2020-30/09/2020):
- Sales revenue: EUR 27.7 million (EUR 22.4 million in the first half of the fiscal year 2019/2020)
- EBITDA: EUR 10.9 million (EUR 6.5 million in the first half of the fis [ … ]